Travoprost (0.004%)

DRUG2 trials

Sponsors

Alcon Research

Conditions

Glaucoma, Angle-ClosureGlaucoma, Open-AngleOcular Hypertension

Phase 3

A 6-Week Safety and Efficacy Study of Travatan Compared to Xalcom in Subjects With Open-Angle Glaucoma(OAG) or Ocular Hypertension(OHT)

CompletedNCT00051155

Alcon ResearchGlaucoma, Open-Angle, Ocular Hypertension

Start: 2001-01-31End: 2004-07-31Updated: 2008-08-05

A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Chronic Angle-Closure Glaucoma

CompletedNCT00051181

Alcon ResearchGlaucoma, Angle-Closure, Ocular Hypertension

Start: 2000-01-31End: 2003-06-30Updated: 2008-08-05